UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Is weight-based IV dosing of trastuzumab preferable to SC fixed-dose in some patients? A systematic scoping review

Breast (Edinburgh), 2021-06, Vol.57, p.95-103

2021

Volltextzugriff (PDF)

Comparison of Methods to Measure Low Serum Estradiol Levels in Postmenopausal Women

The journal of clinical endocrinology and metabolism, 2006-10, Vol.91 (10), p.3791-3797

2006

Volltextzugriff (PDF)

The Totality of Evidence and Use of ABP 215, a Biosimilar to Bevacizumab

Oncology and therapy, 2021-06, Vol.9 (1), p.213-223

2021

Volltextzugriff (PDF)

Clinical Characteristics of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): A Retrospective Chart Review Study

Blood, 2019-11, Vol.134 (Supplement_1), p.4789-4789

2019

Volltextzugriff (PDF)

A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men

Cancer chemotherapy and pharmacology, 2017-10, Vol.80 (4), p.755-763

2017

Volltextzugriff (PDF)

A randomized, single-blind, single-dose study evaluating the pharmacokinetic equivalence of proposed biosimilar ABP 980 and trastuzumab in healthy male subjects

Cancer chemotherapy and pharmacology, 2017-05, Vol.79 (5), p.881-888

2017

Volltextzugriff (PDF)

A randomized, double-blind, single-dose study (LAVENDER) to assess the safety, tolerability, pharmacokinetics, and immunogenicity of a combined infusion of ABP 980 and pertuzumab in healthy subjects

Cancer chemotherapy and pharmacology, 2021-11, Vol.88 (5), p.879-886

2021

Volltextzugriff (PDF)

Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial

The lancet oncology, 2018-07, Vol.19 (7), p.987-998

2018

Volltextzugriff (PDF)

A randomized, single-blind, single-dose study to assess the pharmacokinetic equivalence of the biosimilar ABP 215 and bevacizumab in healthy Japanese male subjects

Cancer chemotherapy and pharmacology, 2018-11, Vol.82 (5), p.899-905

2018

Volltextzugriff (PDF)

Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study

Clinical cancer research, 2019-04, Vol.25 (7), p.2088-2095

2019

Volltextzugriff (PDF)

A randomized, double‐blind, single‐dose, three‐arm, parallel group study to determine pharmacokinetic similarity of ABP 959 and eculizumab (Soliris®) in healthy male subjects

European journal of haematology, 2020-07, Vol.105 (1), p.66-74

2020

Volltextzugriff (PDF)

The effect of ultralow-dose transdermal estradiol on sexual function in postmenopausal women

American journal of obstetrics and gynecology, 2008-03, Vol.198 (3), p.265.e1-265.e7

2008

Volltextzugriff (PDF)

Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide

Menopause (New York, N.Y.), 2007-05, Vol.14 (3 Pt 1), p.408-414

2007

Volltextzugriff (PDF)

Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial

Menopause (New York, N.Y.), 2014-06, Vol.21 (6), p.633-640

2014

Volltextzugriff (PDF)

Biosimilars: what the oncologist should know

Future oncology (London, England), 2019-04, Vol.15 (10), p.1147-1165

2019

Volltextzugriff (PDF)

Abstract OT1-03-04: The importance of central pathology pCR review in an international multicenter neoadjuvant study in HER2 positive early breast cancer - Results of the ABP 980 LILAC trial

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.OT1-03-04-OT1-03-04

2020

Volltextzugriff (PDF)

Efficacy and Safety of Biosimilar Candidate ABP 959 As Compared with Eculizumab Reference Product in Paroxysmal Nocturnal Hemoglobinuria

Blood, 2022-11, Vol.140 (Supplement 1), p.8660-8662

2022

Volltextzugriff (PDF)

Relationship between Pharmacokinetics and Antidrug Antibody Status of ABP 959, a Biosimilar Candidate to Eculizumab: Results from a Pharmacokinetic Similarity Study

Blood, 2019-11, Vol.134 (Supplement_1), p.3520-3520

2019

Volltextzugriff (PDF)

Totality of Scientific Evidence in the Development of ABP 798, a Biosimilar to Rituximab

Blood, 2020-11, Vol.136 (Supplement 1), p.35-36

2020

Volltextzugriff (PDF)

Totality of evidence in development of the bevacizumab biosimilar ABP 215: Central and investigator evaluation of efficacy from the MAPLE study

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e20708-e20708

2019

Volltextzugriff (PDF)

Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria

American journal of hematology, 2024-11, Vol.99 (11), p.2108-2117

2024

Volltextzugriff (PDF)

Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men

Cancer chemotherapy and pharmacology, 2018-02, Vol.81 (2), p.419-419

2018

Volltextzugriff (PDF)

Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study

Drug safety, 2020-03, Vol.43 (3), p.233-242

2020

Volltextzugriff (PDF)

Cardiac safety of the trastuzumab biosimilar ABP 980 in women with HER2-positive early breast cancer in the LILAC study

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.557-557

2019

Volltextzugriff (PDF)

Efficacy and safety of ABP 798 compared with rituximab: Results from the comparative clinical study in patients with non-Hodgkin’s

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.8044-8044

2020

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(72)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

American Journal Of Hypertension
(8)
Journal Of Clinical Oncology
(6)
Cancer Chemotherapy And Pharmacology
(5)
Menopause
(5)
Blood
(4)
Cancer Research
(4)
Targeted Oncology
(3)
Circulation
(2)
Clinical Cancer Research
(2)
Hypertension
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Is weight-based IV dosing of trastuzumab preferable to SC fixed-dose in some patients? A systematic scoping review

Comparison of Methods to Measure Low Serum Estradiol Levels in Postmenopausal Women

The Totality of Evidence and Use of ABP 215, a Biosimilar to Bevacizumab

Clinical Characteristics of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): A Retrospective Chart Review Study

A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men

A randomized, single-blind, single-dose study evaluating the pharmacokinetic equivalence of proposed biosimilar ABP 980 and trastuzumab in healthy male subjects

A randomized, double-blind, single-dose study (LAVENDER) to assess the safety, tolerability, pharmacokinetics, and immunogenicity of a combined infusion of ABP 980 and pertuzumab in healthy subjects

Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial

A randomized, single-blind, single-dose study to assess the pharmacokinetic equivalence of the biosimilar ABP 215 and bevacizumab in healthy Japanese male subjects

Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study

A randomized, double‐blind, single‐dose, three‐arm, parallel group study to determine pharmacokinetic similarity of ABP 959 and eculizumab (Soliris®) in healthy male subjects

The effect of ultralow-dose transdermal estradiol on sexual function in postmenopausal women

Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide

Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial

Biosimilars: what the oncologist should know

Abstract OT1-03-04: The importance of central pathology pCR review in an international multicenter neoadjuvant study in HER2 positive early breast cancer - Results of the ABP 980 LILAC trial

Efficacy and Safety of Biosimilar Candidate ABP 959 As Compared with Eculizumab Reference Product in Paroxysmal Nocturnal Hemoglobinuria

Relationship between Pharmacokinetics and Antidrug Antibody Status of ABP 959, a Biosimilar Candidate to Eculizumab: Results from a Pharmacokinetic Similarity Study

Totality of Scientific Evidence in the Development of ABP 798, a Biosimilar to Rituximab

Totality of evidence in development of the bevacizumab biosimilar ABP 215: Central and investigator evaluation of efficacy from the MAPLE study

Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria

Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men

Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study

Cardiac safety of the trastuzumab biosimilar ABP 980 in women with HER2-positive early breast cancer in the LILAC study

Efficacy and safety of ABP 798 compared with rituximab: Results from the comparative clinical study in patients with non-Hodgkin’s

Suchergebnisse filtern